The present invention relates to an oral composition showing increased adsorption performance of an oil-soluble medicinal ingredient such as glycyrrhetinic acid and tocopherol to the gums and oral mucosa. The invention relates to an oral composition comprising the following ingredients (A), (B), (C), and (D): (A) 0.01 mass% or more and 2.5 mass% or less of one or more oil-soluble medicinal ingredients selected from the group consisting of glycyrrhetinic acid, tocopherol, and a tocopherol derivative； (B) 4 mass% or more and 30 mass% or less of a higher alcohol having 12 or more and 22 or less carbon atoms comprising (b1) cetanol and (b2) stearyl alcohol； (C) 0.1 mass% or more and 10 mass% or less of a surfactant including one or more selected from the group comprising of (c1) a nonionic surfactant selected from the group consisting of sorbitan fatty acid ester and polyoxyethylene sorbitan fatty acid ester, and (c2) an anionic surfactant being a fatty acid having 12 or more and 22 or less carbon atoms or a salt thereof； and (D) water, wherein a mass ratio of the content of (E) an oil agent other than ingredients (A), (B), and (C) and a flavoring agent to the content of ingredient (B), ((E)/(B)), is less than 1； and the content of (F) an abrasive powder comprising a polyvalent metal is 5 mass% or less.
